REGULUS THERAPEUTICS INC's ticker is RGLSXXXX and the CUSIP is 75915K101. A total of 39 filers reported holding REGULUS THERAPEUTICS INC in Q2 2013. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2017 | $78,000 | -26.4% | 47,100 | 0.0% | 0.00% | – |
Q4 2016 | $106,000 | -31.6% | 47,100 | 0.0% | 0.00% | – |
Q3 2016 | $155,000 | +14.0% | 47,100 | 0.0% | 0.00% | – |
Q2 2016 | $136,000 | -11.7% | 47,100 | +112.2% | 0.00% | – |
Q1 2016 | $154,000 | -20.6% | 22,200 | 0.0% | 0.00% | – |
Q4 2015 | $194,000 | +37.6% | 22,200 | +2.8% | 0.00% | – |
Q3 2015 | $141,000 | -40.5% | 21,600 | 0.0% | 0.00% | – |
Q2 2015 | $237,000 | -35.2% | 21,600 | 0.0% | 0.00% | – |
Q1 2015 | $366,000 | +3227.3% | 21,600 | +2985.7% | 0.00% | – |
Q4 2014 | $11,000 | +120.0% | 700 | 0.0% | 0.00% | – |
Q3 2014 | $5,000 | -54.5% | 700 | -50.0% | 0.00% | – |
Q2 2014 | $11,000 | +1000.0% | 1,400 | +827.2% | 0.00% | – |
Q1 2014 | $1,000 | 0.0% | 151 | 0.0% | 0.00% | – |
Q4 2013 | $1,000 | -98.4% | 151 | -97.7% | 0.00% | – |
Q3 2013 | $61,000 | -29.1% | 6,451 | -26.0% | 0.00% | – |
Q2 2013 | $86,000 | – | 8,723 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Abingworth LLP | 327,350 | $943,000 | 0.99% |
DAFNA Capital Management LLC | 421,500 | $1,218,000 | 0.96% |
Rhenman & Partners Asset Management AB | 350,000 | $1,012,000 | 0.18% |
BOURGEON CAPITAL MANAGEMENT LLC | 70,704 | $204,000 | 0.13% |
Piermont Capital Management Inc. | 151,924 | $439,000 | 0.11% |
Virtus ETF Advisers LLC | 46,269 | $134,000 | 0.10% |
COLUMBIA PARTNERS L.L.C. INVESTMENT MANAGEMENT | 389,144 | $1,124,000 | 0.08% |
GLOBEFLEX CAPITAL L P | 80,637 | $233,000 | 0.06% |
South Dakota Investment Council | 900,000 | $2,601,000 | 0.06% |
FOX RUN MANAGEMENT, L.L.C. | 33,100 | $96,000 | 0.05% |